Latest Reimbursement News

Echo IQ has completed its presentation to the CPT Editorial Panel for a Category III CPT code for EchoSolv AS, with a decision expected from the American Medical Association in the coming weeks. Meanwhile, the company is advancing US deployments and FDA clearance efforts.

BCAL Diagnostics has partnered with US-based ClearNote Health to exclusively distribute innovative blood tests for early detection of pancreatic and ovarian cancers in Australia and New Zealand, starting early 2026.

EBR Systems has achieved a significant commercial milestone with its tenth US implant of the WiSE wireless cardiac pacing system, setting the stage for broader market adoption supported by new reimbursement schemes.

Adherium Limited’s iCARE study reports unprecedented medication adherence improvements and sustained patient engagement in COPD and asthma care, highlighting significant clinical and economic benefits.

Gateway Mining Limited has acquired an 80% interest in the Glenburgh South Gold Project in Western Australia, positioning itself alongside Benz Mining Corp’s high-profile Glenburgh deposit. Early exploration hints at promising gold mineralisation, while Gateway prepares for major drilling at its flagship Yandal project.

Medicare contractor Novitas plans to convene an expert panel in early 2026 to review coverage for Pacific Edge’s Cxbladder Triage test following the 2025 update to the American Urological Association microhematuria guideline.

PolyNovo’s NovoSorb BTM, combined with negative pressure wound therapy, significantly accelerates healing of large post-surgical diabetic foot wounds, according to new clinical trial data.

AssetOwl Limited has secured two new technology development contracts worth over A$550,000, marking a strategic push into sustainable energy solutions. Executive Director Bevan Dooley will spearhead these initiatives, signaling a renewed focus on innovation and growth.

The US Centers for Medicare & Medicaid Services has recommended a final reimbursement price of US$1,328 for Pacific Edge’s advanced bladder cancer diagnostic test, Cxbladder Triage Plus, marking a significant increase from earlier proposals.

CZR Resources has completed the sale of its Robe Mesa Iron Ore Project, netting over A$70 million and wiping out its debt. The company is now poised to accelerate exploration across its remaining Western Australian assets.

Artrya Limited has raised A$75 million through a two-tranche placement and launched a A$5 million share purchase plan to fast-track the U.S. commercialisation of its AI-powered Salix platform following FDA clearance.

Tali Resources has completed its initial reverse circulation drilling program at the West Arunta Project, with assay results expected in the December quarter. The company is advancing further exploration activities backed by government incentives.